Janusinfo är avsedd för läkare och sjukvårdspersonal. Patienter och allmänhet hänvisas till Vårdguiden.



E-tjänster läkemedel
Läkemedel och amning / Referenser

Referenser


  1. Somogyi A, Gugler R. Cimetidine excretion into breast milk. Br J Clin Pharmacol 1979; 7: 627-9.
  2. Drugline nr 17324, 1999-12-13.
  3. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 328-9.
  4. Drugline nr 15988, 1999-10-15.
  5. Marshall JK. Thompson AB. Armstrong D. Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol 1998; 12: 225-7.
  6. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998: 1040-2.
  7. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998: 289-91.
  8. Drugline nr 13281, 1998-02-03.
  9. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998: 500-2.
  10. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998: 73-81.
  11. Spigset O, Hagg S. Analgesics and breast-feeding: safety considerations. Paediatr Drugs 2000; 2: 223-38.
  12. Drugline nr 10589, 1992-11-04.
  13. Clark SL, Porter TF, West FG. Coumarin derivatives and breast-feeding. Obstet Gynecol 2000; 95: 938-40.
  14. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 231-2.
  15. Drugline nr 03766, 1983-08-05.
  16. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 233-4.
  17. Drugline nr 05352, 1986-12-03.
  18. Drugline nr 05653, 1987-05-26.
  19. Drugline nr 04909, 1985-11-26.
  20. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998: 474-6.
  21. Drugline nr 05305, 1986-10-22.
  22. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 241-2.
  23. Drugline nr 05008, 1986-02-14.
  24. Drugline nr 08885, 1992-08-27.
  25. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 259-60.
  26. Drugline nr 06667, 1989-05-10.
  27. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 208-9.
  28. Drugline nr 13825, 1996-09-11.
  29. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998: 81-6.
  30. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 235-6.
  31. Drugline nr 14183, 1997-05-09.
  32. Drugline nr 08268, 1988-12-13.
  33. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 267-8.
  34. Drugline nr 17319, 2000-09-15.
  35. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 214-15.
  36. Drugline nr 11137, 1994-06-16.
  37. Devlin RG, Fleiss PM. Captopril in human blood and breast milk. J Clin Pharmacol 1981; 21: 110-3.
  38. Drugline nr 10350, 1994-04-15.
  39. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 301-2.
  40. Drugline nr 16972, 2000-11-06.
  41. Pons G, Rey E, Richard MO, Vauzelle F, Francoual C, Moran C, et al. Nitrofurantoin excretion in human milk. Developmental Pharmacolgy & Therapeutics 1990; 14: 148-52.
  42. Drugline nr 20428, 2003-10-30.
  43. Allgen LG, Holmberg G, Persson B, Sorbo B. Biological fate of methenamine in man. Absorption, renal excretion and passage to umbilical cord blood, amniotic fluid and breast milk. Acta Obstet Gynecol Scand 1979; 58: 287-93.
  44. Drugline nr 05465, 1987-02-25.
  45. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 308-9.
  46. Drugline nr 11473, 1994-08-25.
  47. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 312-13.
  48. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 606-10.
  49. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 310-11.
  50. Drugline nr 14761, 1998-05-15.
  51. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 283-4.
  52. Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000; 85: 3233-8.
  53. Drugline nr 05733, 1987-08-10.
  54. Drugline nr 08853, 1992-09-24.
  55. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 52.
  56. Matheson I, Samseth M, Sande HA. Ampicillin in breast milk during puerperal infections. Eur J Clin Pharmacol 1988; 34: 657-9.
  57. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 81-2.
  58. Drugline nr 03495, 1983-01-24.
  59. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 79-80.
  60. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 89-90.
  61. Drugline nr 10809, 1993-12-10.
  62. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 628.
  63. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 126-7.
  64. Drugline nr 06109, 1988-04-20.
  65. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 1061-3.
  66. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 188-9.
  67. Drugline nr 05881, 1987-11-03.
  68. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 394-5.
  69. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 164-5.
  70. Drugline nr 11786, 1995-01-05.
  71. Alef K. Clostridium difficile-associated disease. Implications for midwifery practice. J Nurse Midwifery 1999; 44: 19-29.
  72. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 722-6.
  73. Drugline nr 09904, 1993-07-28.
  74. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 787-91.
  75. Drugline nr 10854, 1994-01-04.
  76. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 133-4.
  77. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 210-4.
  78. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 334-6.
  79. Drugline nr 08947, 1992-11-04.
  80. Eeg-Olofsson O, Malmros I, Elwin CE, Steen B. Convulsions in a breast-fed infant after maternal indomethacin. Lancet 1978; 2: 215.
  81. Drugline nr 17412, 2001-01-25.
  82. Drugline nr 06401, 1988-11-09.
  83. Drugline nr 15884, 1999-03-02.
  84. Drugline nr 11607, 1994-09-30.
  85. Ortega D, Viviand X, Lorec AM, Gamerre M, Martin C, Bruguerolle B. Excretion of lidocaine and bupivacaine in breast milk following epidural anesthesia for cesarean delivery. Acta Anaesthesiol Scand 1999; 43: 394-7.
  86. Drugline nr 05682, 1987-06-17.
  87. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 456-7.
  88. Drugline nr 08361, 1991-06-14.
  89. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 419-20.
  90. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 254-5.
  91. Drugline nr 12994, 1996-09-26.
  92. Kunka RL, Venkataramanan R, Stern RM, Ladik CF. Excretion of propoxyphene and norpropoxyphene in breast milk. Clin Pharmacol Ther 1984; 35: 675-80.
  93. Drugline nr 09616, 1993-01-11.
  94. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 957.
  95. Wojnar-Horton RE, Kristensen JH, Yapp P, Ilett KF, Dusci LJ, Hackett LP. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. Br J Clin Pharmacol 1997; 44: 543-7.
  96. Drugline nr 13209, 1997-11-24.
  97. Drugline nr 12409, 1995-12-22.
  98. Drugline nr 05464, 1987-02-25.
  99. Drugline nr 05012, 1986-02-17.
  100. Drugline nr 06907, 1989-10-16.
  101. Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf 2000; 22: 425-40.
  102. Winkler SR. Antiepileptic drug use during breastfeeding. J Hum Lact 1999; 15: 63-6.
  103. Drugline nr 05649, 1987-05-25.
  104. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 481-2.
  105. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 487-9.
  106. Stahl MM, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997; 130; 1001-3.
  107. Drugline nr 10856, 1994-01-12.
  108. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 479-80.
  109. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 843-8.
  110. Tran A, O'Mahoney T, Rey E, Mai J, Mumford JP, Olive G. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers. Br J Clin Pharmacol 1998; 45: 409-11.
  111. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41: 709-13.
  112. Drugline nr 08296, 1991-03-19.
  113. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 600-4.
  114. Spigset O, Hägg S. Excretion of Psychotropic Drugs into Breast Milk. CNS Drugs 1998; 9: 111-34.
  115. Yoshida K, Smith B, Craggs M, Kumar R. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med 1998; 28: 81-91.
  116. Drugline nr 04076, 1984-03-16.
  117. Drugline nr 07299, 1990-02-09.
  118. Drugline nr 04417, 1984-11-30.
  119. Yoshida K, Smith B, Kumar R. Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. J Psychopharmacol 1999; 13: 64-80.
  120. Drugline nr 08363, 1991-06-14.
  121. Drugline nr 04935, 1985-12-11.
  122. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 436-7.
  123. Drugline nr 17409, 2000-11-30.
  124. Drugline nr 13664, 1996-05-20.
  125. Drugline nr 10945, 1993-12-21.
  126. Drugline nr 13838, 1996-09-18.
  127. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 446-7.
  128. Drugline nr 15544, 1999-02-12.
  129. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 471-2.
  130. Drugline nr 12095, 1995-06-21.
  131. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 469-70.
  132. Matheson I, Lunde PK, Bredesen JE. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol 1990; 30: 787-93.
  133. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 313-18.
  134. Dusci LJ, Good SM, Hall RW, Ilett KF. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br J Clin Pharmacol 1990; 29: 123-6.
  135. Borgatta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol 1997; 37: 186-92.
  136. Drugline nr 14035, 1997-02-04.
  137. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 515-6.
  138. Drugline nr 11053, 1993-10-19.
  139. Drugline nr 12590, 1995-08-22.
  140. Drugline nr 13391, 1997-09-19.
  141. Drugline nr 14881, 1998-07-30.
  142. Drugline nr 17072, 1999-02-16.
  143. Wisner KL, Perel JM, Findling RL, Hinnes RL. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull 1997; 33: 249-51.
  144. Drugline nr 03846, 1983-09-27.
  145. Briggs G, Freeman RK, Yaffe SJe. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998. p. 647.
  146. Drugline nr 03448, 1982-12-14.
  147. Kristensen JH, Ilett KF, Hackett LP, Yapp P, Paech M, Begg EJ. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999; 48: 521-7.
  148. Schmidt K, Olesen OV, Jensen PN. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000; 47: 164-5.
  149. Drugline nr 16124, 1999-08-13.
  150. Rampono J, Kristensen JH, Hackett LP, Paech M, Kohan R, Ilett KF. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br J Clin Pharmacol 2000; 50: 263-8.
  151. Ohman R, Hagg S, Carleborg L, Spigset O. Excretion of paroxetine into breast milk. J Clin Psychiatry 1999; 60: 519-23.
  152. Nordeng H, Bergsholm YK, Bohler E, Spigset O. Overgang av selektive serotoninreopptakshemmere til morsmelk. Tidskr Nor Laegeforen 2001; 121: 199-203.
  153. Dodd S, Stocky A, Buist A, Burrows GD, Maguire K, Norman TR. Sertraline in Paired Blood Plasma and Breast-Milk Samples from Nursing Mothers. Hum Psychopharmacol 2000; 15: 261-4.
  154. Hagg S, Granberg K, Carleborg L. Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol 2000; 49: 286-8.
  155. Piontek CM, Wisner KL, Perel JM, Peindl KS. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001; 62: 111-3.
  156. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 345-6.
  157. Drugline nr 11574, 1994-09-13.
  158. Bennet PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 529-30.
  159. Drugline nr 05339, 1986-11-24.
  160. Drugline nr 05360, 1986-12-08.
  161. Drugline nr 03368, 1982-10-20.
  162. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 199 ????8. p. 628-9.
  163. Olsson B, Bolme P, Dahlstrom B, Marcus C. Excretion of noscapine in human breast milk. Eur J Clin Pharmacol 1986; 30: 213-5. PubMed.
  164. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2002. P 536
  165. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2002. P 1009
  166. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 950
  167. Micromedex(R) Healthcare Series: Micromedex Inc., Englewood, Colorado
  168. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1063
  169. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. baltimore: Williams & Wilkins; 2000. P 773
  170. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1212
  171. Hofmeyer GJ, Sonnendecker EWW. Secretion of the gastrkinetic agent cisapride in human milk. Eur J Clin Pharmacol 1986; 30: 735-6
  172. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 273
  173. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1026
  174. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1458
  175. Drugline Nr 04888, 1985-11-15
  176. Nikodem VC, Hofmeyr GJ. Secretion of the antidiarrhoeal agent loperamide oxide in breast milk. Eur J Clin Pharmacol 1992; 42: 695-6
  177. FASS 2001
  178. Miller LG, Hopkinson JM, Motil KJ, Corboy JE, Andersson S. Disposition of olsalazine and metabolites in breast milk. J Clin Pharmacol 1993; 33: 703-6
  179. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 870
  180. FASS 2001
  181. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 592
  182. Mackey AD, Picciano MF. Maternal folate status during extended lactation and the effect of supplemental folic acid. Am J Clin Nutr 1999; 69: 285-92
  183. Bennet (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  184. Hauser GJ, Almog S. Tirosh M. Spirer Z. Effect of alpha-methyldopa excreted in human milk on the breast-fed infant. Helv Paediatr ???? Acta 1985; 40: 83-6
  185. White WB, Andreoli JW, Cohn RD. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants. Clin Pharmacol Ther 1985; 37: 387-90
  186. Phelps DL, Karim Z. Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk. J Pharm Sci 1977; 66: 1203
  187. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1270
  188. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 196
  189. Dollery C Sir, editor. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999
  190. Drugline Nr 08776, 1992-07-30
  191. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  192. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 997
  193. Carcas AJ, Abad-Santos F, de Rosendo JM, Frias J. Nimodipine transfer into human breast milk and cerebrospinal fluid. Ann Pharmacother 1996; 30: 148-50 PubMed
  194. Okada M, Inoue H, Nakamura Y, Kishimoto M, Suzuki T. Excretion of diltiazem in human milk. N Engl J Med 1985; 312: 992-3 PubMed
  195. Lubbe WF. Use of diltiazem during pregnancy. N Z Med J 1987; 100: 121
  196. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 799
  197. Begg EJ, Robson RA, Gardiner SJ, Hudson LJ, Reece PA, Olson SC, Posvar EL, Sedman AJ. Quinapril and its metabolite quinaprilat in human milk. Br J Clin Pharmacol 2001; 51: 478-81
  198. Micromedex(R) Healthcare Series: Micromedex Inc., Englewood, Colorado
  199. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 600
  200. Micromedex(R) Healthcare Series: Micromedex Inc., Englewood, Colorado
  201. Micromedex(R) Healthcare Series: Micromedex Inc., Englewood, Colorado
  202. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 813
  203. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 496
  204. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1456
  205. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 728
  206. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 173
  207. Pan H, Fleiss P, Moore L et al. Excretion of pravastatin, an HMG CoA reductase inhibitor, in breast milk of lactating women. J Clin Pharmacol. 1988;28:942. Abstract
  208. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 579
  209. FASS 2001
  210. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 107
  211. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 257
  212. FASS 2001
  213. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 325
  214. FASS 2001
  215. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  216. Drugline Nr 12792, 1995-08-31
  217. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  218. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 210
  219. Briggs G, Freeman RK, ???? Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 207
  220. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 213
  221. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 217
  222. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 203
  223. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 211
  224. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  225. Fleiss PM, Richwald GA, Gordon J, Stern M, Frantz M, Devlin RG. Aztreonam in human serum and breast milk. Br J Clin Pharmacol 1985; 19: 509-11
  226. Dollery C Sir, editor. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999
  227. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  228. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  229. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 287
  230. Drugline Nr 12959, 1996-03-20
  231. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1302
  232. Drugline Nr 13254, 1997-06-10
  233. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 975
  234. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 770
  235. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  236. Drugline Nr 17118, 2000-03-01
  237. Drugline Nr 13176, 1997-06-10
  238. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 538
  239. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1163
  240. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 254
  241. Drugline Nr 06995,1989-12-06
  242. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  243. Sedlmayr T, Peters F, Raasch W, Kees F: Clarithromycin, ein neues Makrolid-Antibiotikum. Wirksamkeit bei puerperalen Infektionen und Ubertritt in die Muttermilch. Geburtshilfe Frauenheilkd 1993; 53: 488-91
  244. Drugline nr 14587, 1998-01-19
  245. Kelsey JJ, Moser LR, Jennings JC, Munger MA. Presence of azithromycin breast milk concentrations: a case report. Am J Obstet Gynecol 1994; 170: 1375-6
  246. Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989; 87: 49-51
  247. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 783
  248. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  249. Micromedex
  250. Micromedex
  251. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  252. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  253. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 557
  254. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 746
  255. Dollery C Sir, editor. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999
  256. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1223
  257. Dollery C Sir, editor. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999
  258. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  259. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 732
  260. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 509
  261. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1298
  262. Drugline Nr 06401,1988-11-09
  263. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 756
  264. Drugline Nr 19319, 2002-09-20
  265. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  266. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1139
  267. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  268. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  269. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 754
  270. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 962
  271. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  272. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  273. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  274. Nordeng H, Zahlsen K, Spigset O: Transfer of carisoprodol to breast milk. Ther Drug Monit 2001; 23: 298-300
  275. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  276. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 38
  277. Gerdin E, Bondesson U, Hartvig P Excretion of ketobemidone in human breast milk. J Perinat Med 1996; 24: 293-5
  278. Drugline nr 16068, 1999-07-08
  279. Drugline nr 19104, 2002-04-04
  280. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1370
  281. Drugline 19205, 2002-07-30
  282. Berlin CM Jr, Vesell ES. Antipyrine disposition in milk and saliva of lactating women. Clin Pharmacol Ther 1982; (1): 38-44
  283. Drugline 19306, 2002-09-25
  284. Hill RC, McIvor RJ, Wojnar-Horton RE, Hackett LP, Ilett KF. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 2000; 20: 285-6
  285. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  286. Drugline 05383, 1986-12-12
  287. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 158
  288. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  289. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  290. Drugline 06063, 1988-03-15
  291. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  292. Drugline 08363, 1991-06-14
  293. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1358
  294. Drugline 19295, 2002-09-26
  295. Drugline 15328, 1999-03-02
  296. Drugline 12825, 1995-09-08
  297. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 979
  298. Dodd S, Buist A, Burrows GD, Maguire KP, Norman TR. Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1999; 730: 249-55
  299. Yapp P, Ilett KF, Kristensen JH, Hackett LP, Paech MJ, Rampono J. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 2000; 34: 1269-72
  300. Drugline 19426, 2002-11-04
  301. Ilett KF, Kristensen JH, Hackett LP, Paech M, Kohan R, Rampono J. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002; 53: 17-22
  302. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  303. Drugline 11216, 1994-09-23
  304. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  305. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  306. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 673
  307. Drugline 08852, 1992-09-22
  308. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 854
  309. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  310. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  311. FASS 2002
  312. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 1210
  313. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  314. Briggs, G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 6th ed. Baltimore: Williams & Wilkins; 2000. P 842
  315. Drugline 10577, 1993-01-27
  316. Drugline 11001, 1994-04-20
  317. Dollery C Sir, editor. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999
  318. Drugline 04667, 1985-05-30
  319. Drugline 03083, 1982-03-10
  320. Bennet PN (ed), Drugs and human lactation. 2nd ed. Amsterdam: Elsevier; 1996
  321. Drugline nr 20721, 2004-03-01
  322. Drugline nr 19943, 2003-05-06
  323. Drugline nr 20894, 2004-04-13
  324. Drugline nr 20992, 2004-02-27
  325. Drugline nr 20403, 2003-09-26
  326. Drugline nr 20429, 2003-10-29
  327. Drugline nr 19971, 2003-04-04
  328. Enoxaparin sodium. Martindale - The Complete Drug Reference. Thomson MICROMEDEX, Greenwood Village, Colorado
  329. Drugline nr 19971, 2003-04-04
  330. Drugline nr 19857, 2003-04-02
  331. Drugline nr 20047, 2003-05-12
  332. Drugline nr 22285, 2005-08-25
  333. Drugline nr 22142, 2005-07-11
  334. Drugline nr 22271, 2005-08-25
  335. Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006;368:704. PubMed
  336. Drugline nr 22344, 2005-09-23
  337. Drugline nr 22478, 2005-11-02
  338. Drugline nr 22553, 2005-11-02
  339. Drugline nr 22980, 2006-08-30.
  340. Drugline nr 21587, 2004-11-19
  341. Drugline nr 22661, 2004-12-14
  342. Drugline nr 22657, 2005-06-17
  343. Rains CP, Bryson HM, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs. 1995 Feb;49:255-79 PubMed
  344. Drugline nr 22063, 2005-05-30
  345. Drugline nr 21735, 2004-11-12
  346. Drugline nr 21558, 2004-11-19
  347. Drugline nr 23092, 2006-10-31
  348. Drugline nr 22350, 2005-09-23
  349. Drugline nr 22661, 2004-12-14
  350. Drugline nr 8083, 1989-08-16
  351. Drugline nr 21817, 2005-02-16.
  352. Drugline nr 23098, 2006-11-08.
  353. Drugline nr 21800, 2005-02-08.
  354. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255-8. PubMed
  355. Drugline nr 6362, 1988-05-11.
  356. Drugline nr 22913, 2005-08-25.
  357. Drugline nr 23383, 2006-10-25.
  358. Data on file, Lilly Research Laboratories
  359. Drugline nr 23217, 2005-08-25.
  360. Drugline nr 23296, 2007-04-23.
  361. Lunell NO, Kulas J, Rane A. Transfer of Labetalol into amniotic fluid and breast milk in lactating women. Eur J Clin Pharmacol. 1985;28:597-99. PubMed
  362. Michael CA. Use of labetalol in the treatment of severe hypertension during pregnancy. Br J Clin Pharmacol. 1979;8(Suppl 2):211S-5S. PubMed
  363. Radwanski E, Nagabhushan N, Affrime MB, Perentesis G, Symchowicz S, Patrick JE. Secretion of dilevalol in breast milk. J Clin Pharmacol. 1988;28:448-53. PubMed
  364. Pons G, Francoual C, Guillet P, Moran C, Hermann P, Bianchetti G et al. Zolpidem excretion in breast milk. Eur J Clin Pharmacol. 1989;37:245-8. PubMed
  365. Darwish M, Martin PT, Cevallos WH, Tse S, Wheeler S, Troy SM. Rapid disappearance of zaleplon from breast milk after oral administration to lactating mothers. J Clin Pharmacol. 1999;39:670-4. PubMed
  366. Drugline nr 23327, 2007-03-27.
  367. Drugline nr 17475, 2001-01-03.
  368. Yentreve (duloxetin). Produktresumé (SPC). Lilly
  369. Drugline nr 23243, 2007-03-13.
  370. Krüninger U, Meltzer V, Heinke C, Herpich S, Schreiber W. Pregnancy and lactation under treatment with quetiapine. Psychiatrische Praxis 2007;34(Suppl 1):S75-S76
  371. Schlotterbeck P, Leube D, Kircher T, Hiemke C, Grunder G. Aripiprazole in human milk. Int J Neuropsychopharmacol 2007;10(3):433. PubMed
  372. Drugline nr 22638, 2006-01-18.
  373. FDA Center for Drug Evaluation and Research. NDA 21-016. Clinical pharmacology and biopharmaceutics reviews. 2002;8-9 FDA. (citerad 2007-12-13)
  374. Tunstall ME, Campbell DM, Dawson BM, Jostell KG. Chlormethiazole treatment and breast feeding. Br J Obstet Gynaecol 1979;86(10):793-8. PubMed
  375. Drugline nr 3384, 1982-11-02.
  376. Barnes J, Anderson LA, Phillipson JD. Herbal medicines. A guide for healthcare professionals. 3rd ed. London: The Pharmaceutical Press; 2007
  377. Clemens JD, Sack DA, Chakraborty J, Rao MR, Ahmed F, Harris JR et al. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. Vaccine 1990;8(5):469-72. PubMed
  378. Jertborn M, Svennerholm AM, Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol 1986;24(2):203-9. PubMed
  379. Grimm D, Pauly E, Pöschl J, Linderkamp O,Skopp G. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2005;27(4):526-30. PubMed
  380. Briggs GG, Samson JH, Ambrose PJ, Schroeder DH. Excretion of bupropion in breast milk. Ann Pharmacother 1993;27(4):431-3. PubMed
  381. Haas JS, Kaplan CP, Barenboim D, Jacob P, III, Benowitz NL. Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use. Tob Control 2004;13(1):52-6. PubMed
  382. Baab SW, Peindl KS, Piontek CM, Wisner KL. Serum bupropion levels in 2 breastfeeding mother-infant pairs. J Clin Psychiatry 2002;63(10):910-1. PubMed
  383. Chaudron LH, Schoenecker CJ. Bupropion and breastfeeding: a case of a possible infant seizure. J Clin Psychiatry 2004;65(6):881-2. PubMed
  384. Drugline nr 21551, 2004-11-18.
  385. Drugline nr 20803, 2004-03-26.
  386. Fass 2007
  387. Geraghty B, Graham EA, Logan B, Weiss EL. Methadone levels in breast milk. J Hum Lact 1997;13(3):227-230. PubMed
  388. McCarthy JJ, Posey BL. Methadone levels in human milk. J Hum Lact 2000;16(2):115-120. PubMed
  389. Begg EJ, Malpas TJ, Hackett LP, Ilett KF. Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing. Br J Clin Pharmacol 2001;52(6):681-685. PubMed
  390. Jansson LM, Choo RE, Harrow C, Velez M, Schroeder JR, Lowe R et al. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J Hum Lact 2007;23(2):184-190. PubMed
  391. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006;117(6):e1163-9. PubMed
  392. Smialek JE, Monforte JR, Aronow R, Spitz WU. Methadone deaths in children. A continuing problem. JAMA. 1977;238(23):2516-7. PubMed
  393. Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker WW. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 1994;151(6):945. PubMed
  394. Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatry Clin Neurosci 2007;19(2):196-197. PubMed
  395. Lactmed (Dev VJ, Krupp P "Adverse events profile and safety of clozapine" Rev Contemp Pharmacother. 1995;6:197-208)
  396. Wiles DH, Orr MW, Kolakowska T. Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 1978;5(3):272-273. PubMed
  397. Olesen OV, Bartels U, Poulsen JH. Perphenazine in breast milk and serum. Am J Psychiatry 1990;147(10):1378-1379. PubMed
  398. Matheson I, Evang A, Overø KF, Syversen G. Presence of chlorprothixene and its metabolites in breast milk. Eur J Clin Pharmacol. 1984;27(5):611-3. PubMed
  399. Whalley LJ, Blain PG, Prime JK. Haloperidol secreted in breast milk. Br Med J (Clin Res Ed) 1981;282(6278):1746-1747. PubMed
  400. Stewart RB, Karas B, Springer PK. Haloperidol excretion in human milk. Am J Psychiatry 1980;137(7):849-850. PubMed
  401. Ohkubo T, Shimoyama R, Sugawara K. Measurement of haloperidol in human breast milk by high-performance liquid chromatography. J Pharm Sci 1992;81(9):947-949. PubMed
  402. Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003;160(8):1428-1431. PubMed
  403. Croke S, Buist A, Hackett LP, Ilett KF, Norman TR, Burrows GD. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002;5(3):243-247. PubMed
  404. Kirchheiner J, Berghofer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000;33(2):78-80. PubMed
  405. Drugline nr 20197, 2003-07-28.
  406. Kirk L, Jørgensen A. Concentrations of Cis(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum, and milk. Psychopharmacology (Berl). 1980;72(1):107-8. PubMed
  407. Matheson I, Skjaeraasen J. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients. Eur J Clin Pharmacol. 1988;35(2):217-20. PubMed
  408. Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg EJ. Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 2004;38(2):273-276. PubMed
  409. Aichhorn W, Stuppaeck C, Whitworth AB. Risperidone and breast-feeding. J Psychopharmacol 2005;19(2):211-213. PubMed
  410. Ratnayake T, Libretto SE. No complications with risperidone treatment before and throughout pregnancy and during the nursing period. J Clin Psychiatry 2002;63(1):76-77. PubMed
  411. Ohkubo T, Shimoyama R, Sugawara K. High performance liquid chromatographic determination of levomepromazine in human breast milk and serum using solid phase extraction. Biomed Chromatogr 1993;7(4):227-228. PubMed
  412. Aaes-Jorgensen T Bjorndal F, Bartels U. Zuclopenthixol levels in serum and breast milk. Psychopharmacology (Berl) 1986;90(3):417-8. PubMed
  413. Wortsman J, Soler NG, Hirschowitz J. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome. Ann Intern Med 1979;90(6):923-5. PubMed
  414. Hilbert J, Radwanski E, Affrime MB, Perentesis G, Symchowicz S, Zampaglione N. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988;28(3):234-9. PubMed
  415. Kok TH, Taitz LS, Bennett MJ, Holt DW. Drowsiness due to clemastine transmitted in breast milk. Lancet 1982;1(8277):914-5. PubMed
  416. Drugline nr 22886, 2005-11-02.
  417. Moretti ME, Verjee Z, Ito S, Koren G. Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2006;40(12):2269-72. PubMed
  418. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: is it safe? BJOG 2007;114(4):498-501. PubMed
  419. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc 1982;14(3):605-9. PubMed
  420. Christensen LA, Dahlerup JF, Schmiegelow K. Excretion of azathioprine metabolites in maternal milk. Gut 2005;54(Suppl VII):A45.
  421. Kane SV, Present DH. Metabolites to immunomodulators are not detected in brest milk. Am J Gastroenterol 2004;99(10 Suppl):246-7.
  422. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006;62(4):453-6. PubMed
  423. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Comment: Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2007;41(4):719-20. PubMed
  424. Bernard N, Garayt C, Chol F, Vial T, Descotes J. Prospective clinical and biological follow-up of three breastfed babies from azathioprine-treated mothers. Fundam Clin Pharmacol 2007;21(Suppl 1):62-3.
  425. Khare MM, Lott J, Currie A, Howarth E. Is it safe to continue azathioprine in breast feeding mothers? J Obstet Gynaecol 2003;23(Suppl 1):S48.
  426. Grekas DM, Vasiliou SS, Lazarides AN. Immunosuppressive therapy and breast-feeding after renal transplantation. Nephron 1984;37(1):68. PubMed
  427. Nyberg G, Haljamäe U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation. 1998;65(2):253-5 (abstract). PubMed
  428. Azathioprine. Lactmed (drugs and lactation database). Tillgänglig via: Drugs and Lactation Database
  429. Steen B, Rane A, Lönnerholm G, Falk O, Elwin CE, Sjöqvist F. Phenytoin excretion in human breast milk and plasma levels in nursed infants. Ther Drug Monit 1982;4(4):331-4. PubMed
  430. Rane A, Garle M, Borgå O, Sjöqvist F. Plasma disappearance of transplacentally transferred diphenylhydantoin in the newborn studied by mass fragmentography. Clin Pharmacol Ther 1974;15(1):39-45. PubMed
  431. Söderman P, Matheson I. Clonazepam in breast milk. Eur J Pediatr 1988;147(2):212-3. PubMed
  432. Shimoyama R, Ohkubo T, Sugawara K, Ogasawara T, Ozaki T, Kagiya A et al. Monitoring of phenytoin in human breast milk, maternal plasma and cord blood plasma by solid-phase extraction and liquid chromatography. J Pharm Biomed Anal 1998;17(4-5):863-9. PubMed
  433. Mirkin BL. Diphenylhydantoin: placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects. J Pediatr 1971;78(2):329-37. PubMed
  434. Meyer FP, Quednow B, Potrafki A, Walther H. [Pharmacokinetics of anticonvulsants in the perinatal period]. Zentralbl Gynakol 1988;110(19):1195-205. PubMed
  435. Finch E, Lorber J. Methaemoglobinaemia in the newborn probably due to phenytoin excreted in human milk. J Obstet Gynaecol Br Emp 1954;61(6):833-4. PubMed
  436. Koup JR, Rose JQ, Cohen ME. Ethosuximide pharmacokinetics in a pregnant patient and her newborn. Epilepsia 1978;19(6):535-9. PubMed
  437. Rane A, Tunell R. Ethosuximide in human milk and in plasma of a mother and her nursed infant. Br J Clin Pharmacol 1981;12(6):855-8. PubMed
  438. Kuhnz W, Koch S, Jakob S, Hartmann A, Helge H, Nau H. Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status. Br J Clin Pharmacol 1984;18(5):671-7. PubMed
  439. Tomson T, Villen T. Ethosuximide enantiomers in pregnancy and lactation. Ther Drug Monit 1994;16(6):621-3. PubMed
  440. Information från Parke & Davis 1977
  441. Söderman P, Rane A. Ethosuximide and nursing. Acta Pharmacol.Toxicol.(Copenh) 1986; 59[Suppl 5].
  442. Taloxa (felbamat). Produktresumé (SPC). Tillgänglig via: www.fass.se (senast uppdaterad 2004-05-16)
  443. Kaneko S, Sato T, Suzuki K. The levels of anticonvulsants in breast milk. Br J Clin Pharmacol 1979;7(6):624-7. PubMed
  444. Kuhnz W, Koch S, Helge H, Nau H. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behavior. Dev Pharmacol Ther 1988;11(3):147-54. PubMed
  445. Pote M, Kulkarni R, Agarwal M. Phenobarbital toxic levels in a nursing neonate. Indian Pediatr 2004;41(9):963-4. PubMed
  446. Knott C, Reynolds F, Clayden G. Infantile spasms on weaning from breast milk containing anticonvulsants. Lancet 1987;2(8553):272-3. PubMed
  447. Juul S. [Barbiturate poisoning via breast milk?]. Ugeskr Laeger 1969;131(51):2257-8. PubMed
  448. Öhman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 2005;46(10):1621-4. PubMed
  449. Kristensen JH, Ilett KF, Hackett LP, Kohan R. Gabapentin and breastfeeding: a case report. J Hum Lact 2006;22(4):426-8. PubMed
  450. Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 2005;46(5):775-7. PubMed
  451. Pynnönen S, Sillanpää M. Letter: Carbamazepine and mother's milk. Lancet 1975;2(7934):563. PubMed
  452. Kuhnz W, Jager-Roman E, Rating D, Deichl A, Kunze J, Helge H et al. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Pediatr Pharmacol (New York) 1983;3(3-4):199-208. PubMed
  453. Froescher W, Eichelbaum M, Niesen M, Dietrich K, Rausch P. Carbamazepine levels in breast milk. Ther Drug Monit 1984;6(3):266-71. PubMed
  454. Merlob P, Mor N, Litwin A. Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother 1992;26(12):1563-5. PubMed
  455. Shimoyama R, Ohkubo T, Sugawara K. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Ann Clin Biochem 2000;37 ( Pt 2):210-5. PubMed
  456. Niebyl JR, Blake DA, Freeman JM, Luff RD. Carbamazepine levels in pregnancy and lactation. Obstet Gynecol 1979;53(1):139-40. PubMed
  457. Pynnönen S, Kanto J, Sillanpaa M, Erkkola R. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol Toxicol (Copenh) 1977;41(3):244-53. PubMed
  458. Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharmacol 1998;18(2):167-9. PubMed
  459. Schaefer C, editor. Drugs during pregnancy and lactation. Handbook of prescription drugs and comparative risk assessment. Amsterdam: Elsevier; 2001
  460. Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila) 1998;37(1):41-4. PubMed
  461. Frey B, Braegger CP, Ghelfi D. Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. Ann Pharmacother 2002;36(4):644-7. PubMed
  462. Frey B, Schubiger G, Musy JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr 1990;150(2):136-8. PubMed
  463. Fisher JB, Edgren BE, Mammel MC, Coleman JM. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol 1985;66(3 Suppl):34S-35S. PubMed
  464. Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson LM, Stowe ZN. Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series. Pediatrics 1999;104(1):e11. PubMed
  465. Rambeck B, Kurlemann G, Stodieck SR, May TW, Jürgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51(6):481-4. PubMed
  466. Tomson T, Öhman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38(9):1039-41. PubMed
  467. Page-Sharp M, Kristensen JH, Hackett LP, Beran RG, Rampono J, Hale TW et al. Transfer of lamotrigine into breast milk. Ann Pharmacother 2006;40(7-8):1470-1. PubMed
  468. Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 2004;5(1):102-5. PubMed
  469. Ivana K, Milan G, Blanka K, Hana B. Therapeutic monitoring of lamotrigine during delivery, in the neonatal period, and during lactation. Ther Drug Monit 2007;29(4):477.
  470. Gentile S. Lamotrigine in pregnancy and lactation. Arch Womens Ment Health 2005;8(1):57-8.
  471. Pennell P, Ritchie J, Newport D, Liporace J, Montgomery J, Newman M et al. Pharmacokinetics of lamotrigine excretion into human breast milk. Neurology 2006;66(5;Suppl 2):A72-A73
  472. Berry DJ. The disposition of lamotrigine throughout pregnancy. Ther Drug Monit 1999;21(4):450.
  473. Öhman I, Tomson T, Vitols S. Lamotrigine (LTG) pharmacokinetics during delivery and lactation. Ther Drug Monit 1999;21(4):478.
  474. Popescu L, Marceanu M, Moleavin I. Withdrawal of lamotrigine caused by sudden weaning of a newborn: a case report. Epilepsia 2005;46(suppl 6):407.
  475. Tomson T, Palm R, Kallen K, Ben-Menachem E, Soderfeldt B, Danielsson B et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007;48(6):1111-6. PubMed
  476. Johannessen SI, Battino D, Berry DJ, Bialer M, Kramer G, Tomson T, Patsalos PN. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit. 2003;25(3):347-63. PubMed
  477. Krämer G, Hösli I, Glanzmann R, Holzgreve W. Levetiracetam accumulation in human breast milk. Epilepsia 43[Suppl 7], 105. 2002.
  478. Lutz UC, Wiatr G, Gaertner HJ, Bartels M. Oxcarbazepine treatment during breast-feeding: a case report. J Clin Psychopharmacol 2007;27(6):730-2. PubMed
  479. Bülau P, Paar WD, von Unruh GE. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol 1988;34(3):311-3. PubMed
  480. Öhman I, Tomson T. Pharmacokinetics of oxcarbazepine in neonatal period and during lactation. 8th European Congress on Epileptology; 2008
  481. Gentile S. Oxcarbazepine in pregnancy and lactation. Clin Drug Investig 2003;23(10):687. PubMed
  482. Eisenschenk S. Treatment with oxcarbazepine during pregnancy. Neurologist 2006;12(5):249-54. PubMed
  483. Nau H, Rating D, Hauser I, Jager E, Koch S, Helge H. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers. Eur J Clin Pharmacol 1980;18(1):31-42. PubMed
  484. Öhman I, Vitols S, Luef G, Söderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002;43(10):1157-60. PubMed
  485. Fröscher W, Jürges U. [Topiramate used during breast feeding]. Aktuelle Neurologie 2006;33(4):215-7
  486. Öhman I, Luef G, Tomson T. Topiramate kinetics during lactation. Epilepsia 2007;48(Suppl 7):156-7
  487. Alexander FW. Sodium valproate and pregnancy. Arch Dis Child 1979;54(3):240. PubMed
  488. Nau H, Rating D, Koch S, Hauser I, Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981;219(3):768-77. PubMed
  489. von Unruh GE, Froescher W, Hoffmann F, Niesen M. Valproic acid in breast milk: how much is really there? Ther Drug Monit 1984;6(3):272-6. PubMed
  490. Tsuru N, Maeda T, Tsuruoka M. Three cases of delivery under sodium valproate--placental transfer, milk transfer and probable teratogenicity of sodium valproate. Jpn J Psychiatry Neurol 1988;42(1):89-96. PubMed
  491. Dickinson RG, Harland RC, Lynn RK, Smith WB, Gerber N. Transmission of valproic acid (Depakene) across the placenta: half-life of the drug in mother and baby. J Pediatr 1979;94(5):832-5. PubMed
  492. Piontek CM, Baab S, Peindl KS, Wisner KL. Serum valproate levels in 6 breastfeeding mother-infant pairs. J Clin Psychiatry 2000;61(3):170-2. PubMed
  493. Philbert A, Pedersen B, Dam M. Concentration of valproate during pregnancy, in the newborn and in breast milk. Acta Neurol Scand 1985;72(5):460-3. PubMed
  494. Shimoyama R, Ohkubo T, Sugawara K. Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method. Biomed Chromatogr 1999;13(5):370-2. PubMed
  495. Kawada K, Itoh S, Kusaka T, Isobe K, Ishii M. Pharmacokinetics of zonisamide in perinatal period. Brain Dev 2002;24(2):95-7. PubMed
  496. Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP et al. Excretion of indomethacin in breast milk. Br J Clin Pharmacol 1991;32(6):751-4. PubMed
  497. CIBA-Geigy Limited. Report B 100/1983: Plasma and breast milk concentrations of unchanged diclofenac during repeated oral administration of 50 mg VOLTAREN enteric coated tablets. 1983. Basle.
  498. Sioufi A, Stierlin H, Schweitzer P, Botta L, Degen PH, Theobald W et al. Recent findings concerning clinically relevant pharmacokinetics of diclofenac sodium. In: Kass.E., editor. Voltaren - New findings. Bern: Hans Huber Publishers; 1982. 19-30.
  499. Fowler PD. Voltarol: Diclofenac sodium. Clin Rheum Dis 1979;5:427-64.
  500. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997;33(3):184-213. PubMed
  501. Todd PA, Sorkin EM. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988;35(3):244-85. PubMed
  502. Wischnik A, Manth SM, Lloyd J, Bullingham R, Thompson JS. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 1989;36(5):521-4. PubMed
  503. Ostensen M. Piroxicam in human breast milk. Eur J Clin Pharmacol 1983;25(6):829-30. PubMed
  504. Ostensen M, Matheson I, Laufen H. Piroxicam in breast milk after long-term treatment. Eur J Clin Pharmacol 1988;35(5):567-9. PubMed
  505. Heintz RC, Stebler T, Lunell NO, Mueller S, Guentert TW. Excretion of tenoxicam and 5'-hydroxy-tenoxicam into human milk. J Pharm Med 1993;3:57-64.
  506. Townsend RJ, Benedetti TJ, Erickson SH, Cengiz C, Gillespie WR, Gschwend J et al. Excretion of ibuprofen into breast milk. Am J Obstet Gynecol 1984;149(2):184-6. PubMed
  507. Weibert RT, Townsend RJ, Kaiser DG, Naylor AJ. Lack of ibuprofen secretion into human milk. Clin Pharm 1982;1(5):457-8. PubMed
  508. Walter K, Dilger C. Ibuprofen in human milk. Br J Clin Pharmacol 1997;44(2):211-2. PubMed
  509. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993;168(5):1393-9. PubMed
  510. Jamali F, Stevens DR. Naproxen excretion in milk and its uptake by the infant. Drug Intell Clin Pharm 1983;17(12):910-1. PubMed
  511. Fidalgo I, Correa R, Gomez Carrasco JA, Martinez QF. [Acute anemia, rectorrhagia and hematuria caused by ingestion of naproxen]. An Esp Pediatr 1989;30(4):317-9. PubMed
  512. Jacqz-Aigrain E, Serreau R, Boissinot C, Popon M, Sobel A, Michel J et al. Excretion of ketoprofen and nalbuphine in human milk during treatment of maternal pain after delivery. Ther Drug Monit 2007;29(6):815-8. PubMed
  513. Knoppert DC, Stempak D, Baruchel S, Koren G. Celecoxib in human milk: a case report. Pharmacotherapy 2003;23(1):97-100. PubMed
  514. Hale TW, McDonald R, Boger J. Transfer of celecoxib into human milk. J Hum Lact 2004;20(4):397-403. PubMed
  515. Gardiner SJ, Doogue MP, Zhang M, Begg EJ. Quantification of infant exposure to celecoxib through breast milk. Br J Clin Pharmacol 2006;61(1):101-4. PubMed
  516. Hale TW. Medications in breastfeeding mothers of preterm infants. Pediatr Ann 2003;32(5):337-47. PubMed
  517. Thiru Y, Bateman DN, Coulthard MG. Successful breast feeding while mother was taking cyclosporin. BMJ 1997;315(7106):463. PubMed
  518. Munoz-Flores-Thiagarajan KD, Easterling T, Davis C, Bond EF. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol 2001;97(5 Pt 2):816-8. PubMed
  519. Moretti ME, Sgro M, Johnson DW, Sauve RS, Woolgar MJ, Taddio A et al. Cyclosporine excretion into breast milk. Transplantation 2003;75(12):2144-6. PubMed
  520. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, Gulati R, McGrory CH et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2005;69-83. PubMed
  521. Fass 2008
  522. Passmore CM, McElnay JC, Rainey EA, D'Arcy PF. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988;26(1):45-51. PubMed
  523. Heisterberg L, Branebjerg PE. Blood and milk concentrations of metronidazole in mothers and infants. J Perinat Med 1983;11(2):114-20. PubMed
  524. Gray MS, Kane PO, Squires S. Further observations on metronidazole (Flagyl). Brit J vener Dis 1961;37:278-9. PubMed
  525. Clements CJ. Metronidazole and breast feeding. N Z Med J 1980;92(670):329. PubMed
  526. Zeisler JA, Gaarder TD, De Mesquita SA. Lidocaine excretion in breast milk. Drug Intell Clin Pharm 1986;20(9):691-3. PubMed
  527. Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP et al. Excretion of lignocaine and its metabolite monoethylglycinexylidide in breast milk following its use in a dental procedure. A case report. J Clin Periodontol 1993;20(8):606-8. PubMed
  528. Dryden RM, Lo MW. Breast milk lidocaine levels in tumescent liposuction. Plast Reconstr Surg 2000;105(6):2267-8. PubMed
  529. Giuliani M, Grossi GB, Pileri M, Lajolo C, Casparrini G. Could local anesthesia while breast-feeding be harmful to infants? J Pediatr Gastroenterol Nutr 2001;32(2):142-4. PubMed
  530. Plante L, Ferron GM, Unruh M, Mayer PR. Excretion of pantoprazole in human breast. J Reprod Med 2004;49(10):825-7. PubMed
  531. Drugline nr 22667, 2004-08-04.
  532. Abdel-Aleem H, Villar J, Gulmezoglu AM, Mostafa SA, Youssef AA, Shokry M et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003;108(1):25-8. PubMed
  533. Vogel D, Burkhardt T, Rentsch K, Schweer H, Watzer B, Zimmermann R et al. Misoprostol versus methylergometrine: pharmacokinetics in human milk. Am J Obstet Gynecol 2004;191(6):2168-73. PubMed
  534. Shimizu T, Yamashiro Y, Yabuta K. Prostaglandin E1, E2, and F2 alpha in human milk and plasma. Biol Neonate 1992;61(4):222-5. PubMed
  535. Drugline nr 23555, 2008-04-04.
  536. Drugline nr 20096, 2003-06-02.
  537. Madadi P, Koren G, Freeman DJ, Oertel R, Campbell RJ, Trope GE. Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma 2008;17(4):329-31. PubMed
  538. Heikkinen T, Ekblad U, Palo P, Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003;73(4):330-7. PubMed
  539. Hendrick V, Stowe ZN, Altshuler LL, Mintz J, Hwang S, Hostetter A et al. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry 2001;50(10):775-82. PubMed
  540. Kim J, Riggs KW, Misri S, Kent N, Oberlander TF, Grunau RE et al. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. Br J Clin Pharmacol 2006;61(2):155-63. PubMed
  541. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996;36(1):42-7. PubMed
  542. Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005;115(2):411-25. PubMed
  543. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004 Jun;161(6):1066-78. PubMed
  544. Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr (Phila) 2001;40(12):681-4. PubMed
  545. Yoshida K, Smith B, Craggs M, Kumar RC. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998;172:175-8. PubMed
  546. Berle JO, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 2004;65(9):1228-34. PubMed
  547. Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 1992;89(4 Pt 1):676-7. PubMed
  548. Isenberg KE. Excretion of fluoxetine in human breast milk. J Clin Psychiatry 1990;51(4):169. PubMed
  549. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993;32(6):1253-5. PubMed
  550. Epperson CN, Jatlow PI, Czarkowski K, Anderson GM. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics 2003;112(5):e425. PubMed
  551. Chambers CD, Anderson PO, Thomas RG, Dick LM, Felix RJ, Johnson KA et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999;104(5):e61. PubMed
  552. Hendrick V, Smith LM, Hwang S, Altshuler LL, Haynes D. Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 2003;64(4):410-2. PubMed
  553. Rohan A. Drug distribution in human milk. Australian Prescriber 1997;20(4):83-6.
  554. Rampono J, Hackett LP, Kristensen JH, Kohan R, Page-Sharp M, Ilett KF. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk. Br J Clin Pharmacol 2006;62(3):316-22. PubMed
  555. Castberg I, Spigset O. Excretion of escitalopram in breast milk. J Clin Psychopharmacol 2006;26(5):536-8. PubMed
  556. LactMed (citerad 2009-05-26) via TOXNET (Toxicology Data Network)
  557. Potts AL, Young KL, Carter BS, Shenai JP. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. J Perinatol 2007;27(2):120-2. PubMed
  558. CHMP assessment report on Novel influenza (H1N1) outbreak Tamiflu (oseltamivir), Relenza (zanamivir) AMEA/H/A-5.3/1172. Emea
  559. EU-rekommendationer om antivirala läkemdel vid a/H1N1-pandemi. Läkemedelsverket
  560. Wentges-van HN, van EM, van der Laan JW. Oseltamivir and breastfeeding. Int J Infect Dis 2008;12(4):451. PubMed
  561. Lau RJ, Emery MG, Galinsky RE. Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure. Obstet Gynecol 1987;69(3 Pt 2):468-71. PubMed
  562. Meyer LJ, de MP, Sheth N, Spruance S. Acyclovir in human breast milk. Am J Obstet Gynecol 1988;158(3 Pt 1):586-8. PubMed
  563. Taddio A, Klein J, Koren G. Acyclovir excretion in human breast milk. Ann Pharmacother 1994;28(5):585-7. PubMed
  564. Sheffield JS, Fish DN, Hollier LM, Cadematori S, Nobles BJ, Wendel GD, Jr. Acyclovir concentrations in human breast milk after valaciclovir administration. Am J Obstet Gynecol 2002;186(1):100-2. PubMed
  565. Fass
  566. Produktresumé Biklin
  567. Celiloglu M, Celiker S, Guven H, Tuncok Y, Demir N, Erten O. Gentamicin excretion and uptake from breast milk by nursing infant. Obsterics & Gynecology 1994;84(2);263-5. PubMed
  568. Produktresumé Netilyn
  569. Festini F, Ciuti R, Taccetti G, Repetto T, Campana S, De Martino M. Breast-feeding in a woman with cystic fibrosis undergoing antibiotic intravenous treatment. J Matern Fetal Neonatal Med. 2006;19(6):375-6. PubMed
  570. Obermeyer BD, Bergstrom RF, Callaghan JT, Knadler MP, Golichowski A, Rubin A. Secretion of nizatidine into human breast milk after single and multiple doses. Clin Pharmacol Ther 1990;47(6):724-30. PubMed
  571. Courtney TP, shaw RW, Cedar E, Mann SG, Kelly JG. Excretion of famotidine in breast milk. Brit J Clin Pharm 2009;26:639.
  572. Misiewicz JJ, Wormsley KG, editors. Transfer of ranitidine to biological fluids: milk and semen. Oxford: Medicine Publishing Foundation; 1981.
  573. Kearns GL, McConnell RF, Jr., Trang JM, Kluza RB. Appearance of ranitidine in breast milk following multiple dosing. Clin Pharm 1985;4(3):322-4. PubMed
  574. SPC Minifom (dimetikon). AstraZeneca 2007-08-17
  575. Ilett KF, Paech MJ, Page-Sharp M, Sy SK, Kristensen JH, Goy R, Chua S, Christmas T, Scott KL. Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk. Br J Clin Pharmacol 2008;65(5):661-6. PubMed
  576. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J. 2004; 80(942):196-200. PubMed
  577. Wretlind M. Excretion of oxazepam in breast milk. Eur J Clin Pharmacol 1987;33(2):209-10. PubMed
  578. Rane A, Sundwall A, Tomson G. [Oxazepam withdrawal in the neonatal period]. Lakartidningen 1979;76(48):4416-17. PubMed
  579. Reider J, Wendt G. Pharmacokinetics and metabolism of the hypnotic nitrazepam. In: Garattini S, Mussini E, Randall LO, editors. The Benzodiazepines. New York: 1973. 99-127.
  580. Koitabashi T, Satoh N, Takino Y. Intravenous midazolam passage into breast milk. J Anesth 1997;11:242-3.
  581. Whitelaw AG, Cummings AJ, McFadyen IR. Effect of maternal lorazepam on the neonate. Br Med J (Clin Res Ed) 1981;282(6270):1106-8. PubMed
  582. Summerfield RJ, Nielsen MS. Excretion of lorazepam into breast milk. Br J Anaesth 1985;57(10):1042-3. PubMed
  583. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol. 1984;5(2):57-60. PubMed
  584. Jensen OH, Bredesen JE, Lindbaek E. [Excretion of flunitrazepam in breast milk]. Tidsskr Nor Laegeforen 1981;101(8):504-5. PubMed
  585. Kanto J, Aaltonen L, Kangas L. Placental transfer and breast milk levels of flunitrazepam. Curr Ther Res 1979;26(5 November):539-46.
  586. Lutziger H. Konzentrationsbestimmungen und klinisch wirksamkeit von doxycyclin (Vibramycin) in uterus, adnexen und muttermilch. Ther Umsch. 1969;26:476-80. PubMed
  587. Erkkola R, Kanto J. Diazepam and breast-feeding. Lancet 1972;1(7762):1235-6. PubMed
  588. Brandt R. Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittelforschung 1976;26(3):454-7. PubMed
  589. Wesson DR, Camber S, Harkey M, Smith DE. Diazepam and desmethyldiazepam in breast milk. J Psychoactive Drugs 1985;17(1):55- 6. PubMed
  590. Dusci LJ, Good SM, Hall RW, Ilett KF. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br J Clin Pharmacol 1990;29(1):123-6. PubMed
  591. Borgatta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol 1997;37(3):186-92. PubMed
  592. Cole AP, Hailey DM. Diazepam and active metabolite in breast milk and their transfer to the neonate. Arch Dis Child 1975;50(9):741-2. PubMed
  593. Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breast-feeding. Lancet 1972;1(7749):542-3. PubMed
  594. Kafetzis DA, Brater DC, Fanourgakis JE, Voyatzis J, Georgakopoulos P. Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum. Antimicrob Agents Chemother. 1983;23(6):870-3. PubMed
  595. Barr WH, Lin CC, Radwanski E, Lim J, Symchowicz S, Affrime M. The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis. 1991;14(1):93-100. PubMed
  596. Blanco JD, Jorgensen JH, Castaneda YS, Crawford SA. Ceftazidime levels in human breast milk. Antimicrob Agents Chemother. 1983;23 (3):479-80. PubMed
  597. Kafetzis DA, Lazarides CV, Siafas CA, Georgakopoulos PA, Papadatos CJ. Transfer of cefotaxime in human milk and from mother to foetus. J Antimicrob Chemother. 1980 Sep;6 Suppl A:135-41. PubMed
  598. Kafetzis DA, Siafas CA, Georgakopoulos PA, Papadatos CJ. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand. 1981;70(3):285-8. PubMed
  599. Ilett KF, Hackett LP, Ingle B, Bretz PJ. Transfer of probenecid and cephalexin into breast milk. Ann Pharmacother. 2006 May;40(5):986-9. PubMed
  600. Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br J Clin Pharmacol 1995;40(3):231-6. PubMed
  601. Anderson PO, McGuire GG. Neonatal alprazolam withdrawal--possible effects of breast feeding. DICP 1989;23(7-8):614. PubMed
  602. Johansen K, Andersen AN, Kampmann JP, Molholm Hansen JM, Mortensen HB. Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982;23(4):339-41. PubMed
  603. Lamberg BA, Ikonen E, Osterlund K, Teramo K, Pekonen F, Peltola J et al. Antithyroid treatment of maternal hyperthyroidism during lactation. Clin Endocrinol (Oxf) 1984;21(1):81-7. PubMed
  604. Low LC, Lang J, Alexander WD. Excretion of carbimazole and propylthiouracil in breast milk. Lancet 1979;2(8150):1011. PubMed
  605. Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000;85(9):3233-8. PubMed
  606. Holdiness MR. Antituberculosis drugs and breast-feeding. Arch Intern Med 1984;144(9):1888. PubMed
  607. Drobac PC, del CH, Sweetland A, Anca G, Joseph JK, Furin J et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis 2005;40(11):1689-92. PubMed
  608. Kampmann JP, Johansen K, Hansen JM, Helweg J. Propylthiouracil in human milk. Revision of a dogma. Lancet 1980;1(8171):736-7. PubMed
  609. Momotani N, Yamashita R, Makino F, Noh JY, Ishikawa N, Ito K. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol (Oxf) 2000;53(2):177-81. PubMed
  610. Drugline nr 23092, 2006-10-31
  611. Tonn P, Reuter SC, Heimke C, Dahmen N. High mirtazapine plasma levels in infant after breast feeding: case report and review of the literature. Am J Psychiatry. 2007;164:348-9. PubMed
  612. Klier CM, Mossaheb N, Lee A, Zernig G. Mirtazapine and breastfeeding: maternal and infant plasma level. J Clin Psychopharmacol. 2009;29:191-2. PubMed
  613. Drugline nr 23940 (år 2009)
  614. Mitrano JA, Spooner LM, Belliveau P. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants. Pharmacotherapy. 2009 Sep;29(9):1103-9. PubMed
  615. Buitrago MI, Crompton JA, Bertolami S, North DS, Nathan RA. Extermely low excretion of daptomycin into breast Milk of a Nursing Mother with Methicillin-Resistant Staphylococcus aureus Pelvic Inflammatory Disease. Pharmacotherapy. 2009 Mar;29(3):347-51. PubMed
  616. Miller RD, Salter AJ. The passage of trimethoprim/sulfamethoxazole into breast milk and its significance. In: Daikos CK, ed. Progress in Chemotherapy. Antibacterial chemotherapy. 1974;1:687-91.
  617. Baier R, Wolnik L, Puppel H et al. Piperacillin concentrations in milk and serum from lactating women. Proc ICAAC. 1982;203. Abstract 779.
  618. Schaefer, C., Peters, P. and Miller, R.K. Drugs during pregnancy and lactation. 2nd 2007.
  619. Matheson I, Samseth M, Løberg R, Faegri A, Prentice A. 1988 Milk transfer of phenoxymethylpenicillin during puerperal mastitis. Br J Clin Pharmacol. 1988 Jan;25(1):33-40. PubMed
  620. FDA Center for Drug Evaluation and Research. NDA 21-337. Clinical pharmacology and biopharmaceutics reviews. 2008;37-40.
  621. Briggs G, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 8th ed. Baltimore: Williams & Wilkins; 2007.
  622. Chung AM, Reed MD, Blumer JL. Antibiotics and breast-feeding: a critical review of the literature. Paediatr Drugs. 2002;4(12):817-37. Review. PubMed
  623. SPC Inolaxol (sterikuliagummi). Solvay Pharma 2008
  624. Lassman HB, Puri SK, Ho I, Sabo R, Mezzino MJ. Pharmacokinetics of roxithromycin (RU 965). J Clin Pharmacol. 1988; 28(2):141-52. PubMed
  625. Sorensen HT, Skriver MV, Pedersen L et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 2003;35:104-6. PubMed
  626. Findlay JW, Butz RF, Sailstad JM, Warren JT, Welch RM. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers. Br J Clin Pharmacol. 1984 Dec;18(6):901-6. PubMed
  627. Aljazaf K, Hale TW, Ilett KF, Hartmann PE, Mitoulas LR, Kristensen JH, Hackett LP. Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk. Br J Clin Pharmacol. 2003 Jul;56(1):18-24. PubMed
  628. Mortimer EA Jr. Drug toxicity from breast milk? Pediatrics. 1977 Nov;60(5):780-1. PubMed
  629. Lustgarten J S, Podos S M. Topical timolol and the nursing mother. Arch Ophthalmol 1983; (101): 1381-2. PubMed
  630. Sereda B, Bouwman H, Kylin H. Comparing water, bovine milk, and indoor residual spraying as possible sources of DDT and pyrethroid residues in breast milk. J Toxicol Environ Health A 2009; (72): 842-51. PubMed
  631. Nikodem VC, Hofmeyr GJ. Secretion of the antidiarrhoeal agent loperamide oxide in breast milk. Eur J Clin Pharmacol 1992; 42(6):695-6. PubMed
  632. BNFc (British National Formula for Children). London:Medicines complete. Electronic version (2009)
  633. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008
  634. Sedlmayr T, Peters F, Raasch W, Kees F. Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk] Geburtshilfe Frauenheilkd. 1993;53(7):488-91. PubMed
  635. Kelsey JJ, Moser LR, Jennings JC, Munger MA. Presence of azithromycin breast milk concentrations: a case report. Am J Obstet Gynecol. 1994;170(5 Pt 1):1375-6. PubMed
  636. Lonnerholm G, Lindstrom B. Terbutaline excretion into breast milk. Br J Cin Pharmacol 1982;13:729-30. PubMed
  637. Boreus LO, de Chateau PU. Terbutaline in breast milk. Br J Clin Pharmacol 1982;13:731-2. PubMed
  638. Stec GP, Greenberger P, Ruo TI, Henthorn T, Morita Y, Atkinson AJ, Jr., Patterson R: Kinetics of theophylline transfer to breast milk. Clin Pharmacol Ther 1980; 28(3):404-8. PubMed
  639. Reinhardt D, Richter O, Brandenburg G: [Pharmacokinetics of drugs from the breast-feeding mother passing into the body of the infant, using theophylline as an example]. Monatsschr Kinderheilkd 1983; 131(2):66-70. PubMed
  640. Gardner MJ, Schatz M, Cousins L, Zeiger R, Middleton E, Juusko WJ. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol. 1987;32:289-95. PubMed
  641. Hosbach RH, Foster RB. Absence of nitrofurantoin from human milk. JAMA 1967;202(11):1057. PubMed
  642. Gerk PM, Kuhn RJ, Desai NS, McNamara PJ. Active transport of nitrofurantoin into human milk. Pharmacotherapy 2001;21(6):669-75. PubMed
  643. Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. J Pediatr 1973;82(5):886-7. PubMed
  644. Yurchak AM, Jusko WJ: Theophylline secretion into breast milk. Pediatrics 1976; 57(4):518-20. PubMed
  645. Buist A, Dennerstein L, Maguire KP, Norman TR. Human Psychopharmacol Clin Exp 1998;13:579-82.
  646. Allgen LG, Holmberg G, Persson B, Sörbo B. Biological fate of methenamin in man. Absorption, renal excretion and passage to umbilical cord blood, amniotic fluid and breast milk. Acta Obstet Gynecol Scand. 1979;58:287-93. PubMed
  647. Produktresumée Sandomigrin. Novartis 2009.
  648. Saxena BN, Shrimanker K, Grudzinskas JG. Levels of contraceptive seroids in breast milk and plasma of lactating women. Contraception 1977;16(6):605-13. PubMed
  649. Cooke ID, Back DJ, Shroff NE. Norethisterone concentration in breast milk and infant and maternal plasma during ethynodiol diacetate administration. Contraception 1985;31(6):611-21. PubMed
  650. Betrabet SS, Shikary ZK, Toddywalla VS, Toddywalla SP, Patel D, Saxena BN. ICMR Task Force Study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk. Contraception 1987;35(6):517-22. PubMed
  651. Antikonception-Behandlingsrekommendation Information från Läkemedelsverket 7:2005
  652. Van der Molen HJ, Hart PG, Wijmenga HG. Studies with 4-14C-lynestrenol in normal and lactating women. Acta Endocrinol (Copenh) 1969;61(2):255-74. PubMed
  653. Sinchai W, Sethavanich S, Asavapiriyanont S, Sittipiyasakul V, Sirikanchanakul R, Udomkiatsakul P et al. Effects of a progestogen-only pill (Exluton) and an intrauterine device (Multiload Cu250) on breastfeeding. Adv Contracept 1995;11(2):143-55. PubMed
  654. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, Thaithumyanon P, Punnahitananda S, Tosukhowong P et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device. Contraception 2000;62(5):239-46. PubMed
  655. Taneepanichskul S, Reinprayoon D, Thaithumyanon P, Praisuwanna P, Tosukhowong P, Dieben T. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 2006;73(4):368-71. PubMed
  656. Nilsson S, Nygren KG, Johansson ED. Ethinyl estradiol in human milk and plasma after oral administration. Contraception 1978;17(2):131-9. PubMed
  657. Madhavapeddi R, Ramachandran P. Side effects of oral contraceptive use in lactating women--enlargement of breast in a breast-fed child. Contraception 1985;32(5):437-43. PubMed
  658. Curtis EM. Oral-contraceptive feminization of a normal male infant: report of a case. Obstet Gynecol 1964;23:295-6. PubMed
  659. Marriq P, Oddo G. [Letter: Gynecomastia in the newborn induced by maternal milk? An unusual complication of oral contraceptives]. Nouv Presse Med 1974;3(41-43):2579. (Abstrakt) PubMed
  660. Tankeyoon M, Dusitsin N, Chalapati S, Koetsawang S, Saibiang S, Sas M et al. Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives. Contraception 1984;30(6):505-22. PubMed
  661. Lonnerdal B, Forsum E, Hambraeus L. Effect of oral contraceptives on composition and volume of breast milk. Am J Clin Nutr 1980;33(4):816-24. PubMed
  662. FFPRHC Guidance (July 2004): Contraceptive choices for breastfeeding women. J Fam Plann Reprod Health Care 2004;30(3):181-9. PubMed
  663. Blode H, Foidart JM, Heithecker R. Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women. Eur J Contracept Reprod Health Care 2001;6(3):167-71. PubMed
  664. Produktresumée Persantin Depot. Boehringer Ingelheim. 2009
  665. Bjarnadottir RI, Gottfredsdottir H, Sigurdardottir K, Geirsson RT, Dieben TO. Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive device in lactating women. BJOG 2001;108(11):1174-80. PubMed
  666. Stoppelli I, Rainer E, Humpel M. Transfer of cyproterone acetate to the milk of lactating women. Contraception 1980;22(5):485-93. PubMed
  667. Reyes MP, Ostrea Jr. EM, Cabinian AE et al. Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? Am J Obstet Gynecol. 1989;161:977-81. PubMed
  668. Gurpinar AN, Balkan E, Kilic N et al. The effects of a fluoroquinolone on the growth and development of infants. J Int Med Res. 1997;25(5):302-6. PubMed
  669. Giamarellou H, Kolokythas E, Petrikkos G et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med. 1989;87(suppl 5A):49S-51S. PubMed
  670. Cahill JB Jr, Bailey EM, Chien S, Johnson GM. Levofloxacin secretion in breast milk: a case report. Pharmacotherapy. 2005;25(1):116-8. PubMed
  671. Fleiss PM, Richwald GA, Gordon J et al. Aztreonam in human serum and breast milk. Br J Clin Pharmacol. 1985;19:509-11. PubMed
  672. Wischnik A, Wetzelsberger N, Lucker PW. Elimination von nalbuphin in die muttermilch [Elimination of nalbuphine in human milk]. Arzneimittelforschung. 1988;38:1496-8.
  673. Jacqz-Aigrain E, Serreau R, Boissinot C, Popon MJ et al. Excretion of ketoprofen and nalbuphine in human milk during treatment of maternal pain after delivery. Ther Drug Monit. 2007;29:815-8. PubMed
  674. Bouwman H, Sereda B, Meinhardt H M. Simultaneous presence of DDT and pyrethroid residues in human breast milk from a malaria endemic area in South Africa. Environ Pollut 2006; (144): 902-17. PubMed
  675. Nyberg L, Berg E. Utsönding av fenylpropanolamin i bröstmjölk relaterad till substansens plasmakoncentration. Läkaresällskapets Riksstämma; 1979, Läkemedelslära 22.
  676. Steen B, Rane A. Clindamycin passage into human milk. Br J Clin Pharmacol 1982;13(5):661-664. PubMed  
  677. Smith JA. Clindamycin in human breast milk. CMAJ 1975;112(April 5):806. PubMed
  678. Mann CF. Clindamycin and breast-feeding. Pediatrics 1980;66(6):1030-1031. PubMed
  679. Johnson S M, Martinez M, Freedman S. Management of glaucoma in pregnancy and lactation. Surv Ophthalmol 2001; (45): 449-454. PubMed
  680. Feig DS, Briggs GG, Kraemer JM, Ambrose PJ, Moskovitz DN, Nageotte M et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005;28(8):1851-5. PubMed
  681. Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD et al. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos 2010;38(5):833-40. PubMed
  682. Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF. Transfer of metformin into human milk. Diabetologia 2002;45(11):1509-14. PubMed
  683. Briggs GG, Ambrose PJ, Nageotte MP, Padilla G, Wan S. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005;105(6):1437-41. PubMed
  684. Gardiner SJ, Kirkpatrick CM, Begg EJ, Zhang M, Moore MP, Saville DJ. Transfer of metformin into human milk. Clin Pharmacol Ther 2003;73(1):71-7. PubMed
  685. Glueck CJ, Salehi M, Sieve L, Wang P. Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome. J Pediatr 2006;148(5):628-32. PubMed
  686. Sandstrom B, Regardh CG. Metoprolol excretion into breast milk. Br J Clin Pharmacol. 1980;9:518-9. PubMed
  687. Liedholm H, Melander A, Bitzén PO, Helm G, Lönnerholm G, Mattiasson I et al. Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol. 1981;20(3):229-31. PubMed
  688. Kulas J, Lunell NO, Rosing U et al. Atenolol and metoprolol. A comparison of their excretion into human breast milk. Acta Obstet Gynecol Scand Suppl. 1984;suppl 118:65-9. PubMed
  689. Thorley KJ, McAinsh J. Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharm Drug Dispos.1983;Jul-Sep;4(3):299-301. PubMed
  690. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet. 1988;14(4):217-40. PubMed
  691. Smith MT, Livingstone I, Hooper WD, Eadie MJ, Triggs EJ. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma. Ther Drug Monit.1983;5(1):87-93. PubMed
  692. Hackett LP, Wojnar-Horton RE, Dusci LJ et al. Excretion of sotalol in breast milk. Br J Clin Pharmacol. 1990;29(2):277-8. PubMed
  693. O'Hare MF, Murnaghan GA, Russell CJ et al. Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol. 1980;87:814-20. PubMed
  694. Andersen HJ. Excretion of verapamil in human milk. Eur J Clin Pharmacol. 1983;25:279-80. Letter. PubMed
  695. Anderson P, Bondesson U, Mattiasson I et al. Verapamil and norverapamil in plasma and breast milk during breast feeding. Eur J Clin Pharmacol. 1987;31:625-7. PubMed
  696. Ehrenkranz RA , Ackerman BA, Hulse JD. Nifedipine transfer into human milk. J Pediatr. 1989;114(3):478-80. PubMed
  697. Inoue H, Unno N, Ou M-C et al. Level of verapamil in human milk. Eur J Clin Pharmacol. 1984;26:657-8. PubMed
  698. Manninen AK, Juhakoski A. Nifedipine concentrations in maternal and umbilical serum, amniotic flud, breast milk and urine of mothers and offspring. Int J Clin Pharm Res. 1991;11:231-6. PubMed
  699. Penny WJ, Lewis MJ. Nifedipine is excreted in human milk. Eur J Clin Pharmacol. 1989;36(4):427-8. PubMed
  700. Tonks AM. Nimodipine levels in breast milk. Aust N Z J Surg. 1995;65:693-4. PubMed
  701. Maquire A M, Bennett J. Fluorescein elimination in human breast milk. Arch Ophthalmol 1988;(106):718-9. PubMed
  702. Kearns G L, Williams B J, Timmons O D. Fluorescein phototoxicity in a premature infant. J Pediatr 1985;107:796-8. PubMed
  703. Produktresumée Fluoresceinnatrium Chauvin , Novartis, 2006
  704. Mattern J, Mayer P R. Excretion of fluorescein into breast milk. Am J Ophthalmol 1990;109:598-9. PubMed
  705. Cooperman JM, Dweck HS, Newman LJ, Garbarino C, Lopez R. The folate in human milk. Am J Clin Nutr. 1982;36:576-80. PubMed
  706. Tamura T, Yoshimura Y, Arakawa T. Human milk folate and folate status in lactating mothers and their infants. Am J Clin Nutr. 1980;33:193-7. PubMed
  707. Smith AM, Picciano MF, Deering RH. Folate supplementation during lactation: maternal folate status, human milk folate content, and their relationship to infant folate status. J Pediatr Gastroenterol Nutr. 1983;2:622-8. PubMed
  708. Breymann C, von Seefried B, Stahel M, Geisser P, Canclini C. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. J Perinat Med. 2007;35:115-8. PubMed
  709. Canfield LM, Clandinin MT, Davies DP, Fernandez MC, Jackson J, Hawkes J, Goldman WJ, Pramuk K, Reyes H, Sablan B, Sonobe T, Bo X. Multinational study of major breast milk carotenoids of healthy mothers. Eur J Nutr. 2003;42:133-41. PubMed
  710. Haskell MJ, Brown KH. Maternal vitamin A nutriture and the vitamin A content of human milk. J Mammary Gland Biol Neoplasia. 1999;4:243-57. PubMed
  711. Bahl R, Bhandari N, Wahed MA, Kumar GT, Bhan MK; WHO/CHD Immunization-Linked Vitamin A Group. Vitamin A supplementation of women postpartum and of their infants at immunization alters breast milk retinol and infant vitamin A status. J Nutr. 2002;132:3243-8. PubMed
  712. Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol 2001;52(6):708-10. PubMed
  713. Harenberg J, Leber G, Zimmermann R, Schmidt W. [Prevention of thromboembolism with low-molecular weight heparin in pregnancy]. Geburtshilfe Frauenheilkd 1987;47(1):15-8. PubMed
  714. Lindhoff-Last E, Willeke A, Thalhammer C, Nowak G, Bauersachs R. Hirudin treatment in a breastfeeding woman. Lancet 2000;355(9202):467-8. PubMed
  715. Magnani HN. An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran). Thromb Res 2010;125(4):297-302. PubMed
  716. Lindhoff-Last E, Bauersachs R. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost 2002;28(5):439-46. PubMed
  717. Harrison SJ, Rafferty I, McColl MD. Management of heparin allergy during pregnancy with danaparoid. Blood Coagul Fibrinolysis 2001;12(2):157-9. PubMed
  718. Guillonneau M, de CA, Aufrant C, Hurtaud-Roux MF, Jacqz-Aigrain E. [Breast-feeding is possible in case of maternal treatment with enoxaparin]. Arch Pediatr 1996;3(5):513-4. PubMed
  719. Orme ML, Lewis PJ, de SM, Serlin MJ, Sibeon R, Baty JD et al. May mothers given warfarin breast-feed their infants? Br Med J 1977;1(6076):1564-5. PubMed
  720. McKenna R, Cole ER, Vasan U. Is warfarin sodium contraindicated in the lactating mother? J Pediatr 1983;103(2):325-7. PubMed
  721. Dardick KR. Warfarin during lactation. Conn Med 1980;44(11):693. PubMed
  722. Healy M. Suppressing lactation with oral diuretics. Lancet 1961;1353-4.
  723. de G H, Dhont M, Thiery M, Parewyck W. Puerperal lactation suppression and prolactin. Acta Obstet Gynecol Scand 1979; (58): 469-72. PubMed
  724. Stout G. Suppression of lactation. Br Med J. 1962;(21):1150.
  725. Cominos D C, van der W A, van Rooyen A J. Suppression of postpartum lactation with furosemide. S Afr Med J 1976;(50):251-2. PubMed
  726. Miller M E, Cohn R D, Burghart P H. Hydrochlorothiazide disposition in a mother and her breast-fed infant. J Pediatr 1982;(101):789-91. PubMed
  727. Eriksson G, Swahn CG. Concentrations of baclofen in serum and breast milk from a lactating woman. Scand J Clin Lab Invest 1981;41(2):185-7. PubMed
  728. Moran LR, Almeida PG, Worden S, Huttner KM. Intrauterine baclofen exposure: a multidisciplinary approach. Pediatrics 2004;114(2):e267-e269. PubMed
  729. Liedholm H, Wahlin-Boll E, Hanson A, Ingemarsson I, Melander A. Transplacental passage and breast milk concentrations of hydralazine. Eur J Clin Pharmacol 1982;(21):417-9. PubMed
  730. Berlin CM, Jr., Yaffe SJ, Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. Pediatr Pharmacol (New York ) 1980;1(2):135-41. PubMed
  731. Bitzen PO, Gustafsson B, Jostell KG, Melander A, Wahlin-Boll E. Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol 1981;20(2):123-5. PubMed
  732. Notarianni LJ, Oldham HG, Bennett PN. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br J Clin Pharmacol 1987;24(1):63-7. PubMed
  733. Matheson I, Lunde PK, Notarianni L. Infant rash caused by paracetamol in breast milk? Pediatrics 1985;76(4):651-2. PubMed
  734. Diphenhydramine i LactMed via http://toxnet.nlm.nih.gov (citerad 2010-07-23)
  735. Nilsson S, Nygren KG, Johansson ED. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Am J Obstet Gynecol 1977;129(2):178-84. PubMed
  736. Bassol S, Nava-Hernandez MP, Hernandez-Morales C, Trujillo-Macias AM, Lopez-Lozano MR, Recio R. Effects of levonorgestrel implant upon TSH and LH levels in male infants during lactation. Int J Gynaecol Obstet 2002;76(3):273-7. PubMed
  737. Gainer E, Massai R, Lillo S, Reyes V, Forcelledo ML, Caviedes R et al. Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception. Hum Reprod 2007;22(6):1578-84. PubMed
  738. Schiappacasse V, Diaz S, Zepeda A, Alvarado R, Herreros C. Health and growth of infants breastfed by Norplant contraceptive implants users: a six-year follow-up study. Contraception 2002;66(1):57-65. PubMed
  739. Eriksson O, Kjellman H, Nilsson L. Tranexamic acid in human milk after oral administration of cyklokapron to lactating women. Data on file KabiAB. 1971.
  740. Produktresumée Oxibuprokain Chauvin, Novartis, 2009
  741. Milunsky JM. Breast-feeding during colchicine therapy for familial Mediterranean fever. J Pediatr 1991;119 (1 Pt 1):164. PubMed
  742. Ben-Chetrit E, Scherrmann JM, Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum 1996;39(7):1213-7. PubMed
  743. Guillonneau M, Aigrain EJ, Galliot M, Binet MH, Darbois Y. Colchicine is excreted at high concentrations in human breast milk. Eur J Obstet Gynecol Reprod Biol 1995;61(2):177-8. PubMed
  744. Kamilli I, Gresser U, Schaefer C, Zollner N. Allopurinol in breast milk. Adv Exp Med Biol 1991;309A:143-5. PubMed
  745. Kamilli I, Gresser U. Allopurinol and oxypurinol in human breast milk. Clin Investig 1993;71(2):161-4. PubMed
  746. Schimmel MS, Eidelman AI, Wilschanski MA et al. Toxic effects of atenolol consumed during breast feeding. J Pediatr. 1989;114:476-8. PubMed
  747. Shehadeh N, Khaesh-Goldberg E, Shamir R et al. Insulin in human milk: postpartum changes and effect of gestational age. Arch Dis Child Fetal Neonatal Ed. 2003;88:F214-6. PubMed
  748. Shehadeh N, Shamir R, Berant M et al. Insulin in human milk and the prevention of type 1 diabetes. Pediatr Diabetes. 2001;2(4):175-7. PubMed
  749. SPC Skinoren
  750. LactMed via http://toxnet.nlm.nih.gov (citerad 2010-12-23)
  751. SPC Lamisil
  752. Lenzi E, Santauri S. [Preliminary observations on the use of a synthetic rifamycin derivative]. Atti Accad Lancisiana Roma. 1969;13 (Suppl 1):87-94.
  753. Thulin P C, Woodward W R, Carter J H, Nutt J G. Levodopa in human breast milk: clinical implications. Neurology 1998;(50):1920-1. PubMed
  754. Singh N, Golani A, Patel Z, Maitra A.Transfer of isoniazid from circulation to breast milk in lactating women on chronic therapy for tuberculosis. Br J Clin Pharm. 2008 65(3):418-22. PubMed
  755. Snider DE Jr, Powell KE.Should women taking antituberculosis drugs breast-feed? Arch Intern Med. 1984 Mar;144(3):589-90. PubMed
  756. Briggs G, Ambrose P, Follet K, Hackett P, Nageotte M, Padilla G. Use of Duloxetine in Pregnancy and Lactation. Annals of Pharmacotherapy 2009;43:1898-1902. PubMed
  757. Lobo E et al. Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women. Clin Pharmacokinet 2008;47:103-9. PubMed
  758. Ben-Baruch G, Menczer J, Goshen R, Kaufman B, Gorodetsky R. Cisplatin excretion in human milk. J Natl Cancer Inst. 1992;84(6):451-2. PubMed
  759. SPC Akineton
  760. Matsota PK, Markantonis SL, Fousteri MZ, Pandazi AK, Manikis DE, Christodoulopoulou TC et al. Excretion of ropivacaine in breast milk during patient-controlled epidural analgesia after cesarean delivery. Reg Anesth Pain Med 2009;34(2):126-9. PubMed
  761. Brixen-Rasmussen L, Halgrener J, Jorgensen A. Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology. 1982;76:94-5. PubMed
  762. Berlin CM Jr, Denson HM, Daniel CH, Ward RM. Disposition of dietary caffeine in milk, saliva, and plasma of lactating women. Pediatrics. 1984;73:59-63. PubMed
  763. Ryu JE. Effect of maternal caffeine consumption on heart rate and sleep time of breast-fed infants. Dev Pharmacol Ther. 1985;8:355-63. PubMed
  764. Bader TF, Newman K. Amitriptyline in human breast milk and the nursing infant's serum. Am J Psychiatry. 1980;137:855-6. PubMed
  765. Schimmell MS, Zylber Katz E, Shaag Y et al. Toxic neonatal effects following maternal clomipramine therapy. Clin Toxicol. 1991;29:479-84. PubMed
  766. Yoshida K, Smith B, Craggs M et al. Investigation of pharmacokinetics and possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affective Disord. 1997;43:225-37. PubMed
  767. Wisner KL, Perel JM, Foglia JP. Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry. 1995;56:17-20. PubMed
  768. Huttunen K, Gronhagen-Riska C, Fyhrquist F. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol. 1989;31:278. Letter. PubMed
  769. Rush JE, Snyder DL, Barrish A et al. Comment on Huttunen K, Gronhagen-Riska C, Fyrquist F. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol. 1989;31:278. Clin Nephrol. 1991;35:234. Letter. PubMed
  770. Redman CWG, Kelly JG, Cooper WD. The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol. 1990;38:99. PubMed
  771. Eyal S, Kim JD, Anderson GD et al. Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum. J Clin Pharmacol. 2010;50:1301-9. PubMed
  772. Peters F, Geisthovel F, Breckwoldt M. Serum prolactin levels in women with excessive milk production. Normalization by transitory prolactin inhibition. Acta Endocrinol Copenh). 1985;(109):463-6. PubMed
  773. Verma S, Shah D, Faridi M M. Breastfeeding a baby with mother on Bromocripine. Indian J Pediatr 2006;(73):435-6. PubMed
  774. Canales E S, Garcia I C, Ruiz J E, Zarate A. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil Steril 1981;(36):524-6. PubMed

Uppdaterad: 2011-03-26

« Tillbaka
Skriv ut sidan Skriv ut pdf